{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:25:39Z","timestamp":1794029139931,"version":"4.8.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020627","name":"Kerman Neuroscience Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.neuropharm.2026.111230","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:57:46Z","timestamp":1792249066000},"page":"111230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic potential and toxicological trade-offs of nanoparticle-enhanced valproic acid in glioblastoma: Behavioral and oxidative insights"],"prefix":"10.1016","volume":"302","author":[{"given":"Negin","family":"Khodayari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Sedghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Pashazadeh Azari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Houshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Shahrokhi Raeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merat","family":"Mahmoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8818-0170","authenticated-orcid":false,"given":"Hamideh","family":"Bashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Kheirandish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuropharm.2026.111230_bib1","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1002\/jcb.27700","article-title":"The study of the serum level of IL-4, TGF-\u03b2, IFN-\u03b3, and IL-6 in overweight patients with and without diabetes mellitus and hypertension","volume":"120","author":"Asadikaram","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111230_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","article-title":"Valproic acid use during radiation therapy for glioblastoma associated with improved survival","volume":"86","author":"Barker","year":"2013","journal-title":"Int. J. Radiat. Oncol."},{"issue":"xxxx","key":"10.1016\/j.neuropharm.2026.111230_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.matpr.2020.04.109","article-title":"Solid lipid nanoparticles for oral drug delivery","volume":"36","author":"Basha","year":"2021","journal-title":"Mater. Today Proc."},{"key":"10.1016\/j.neuropharm.2026.111230_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.neuropharm.2016.02.010","article-title":"Modulatory effects of the basolateral amygdala \u03b12-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze","volume":"105","author":"Bashiri","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111230_bib5","first-page":"223","article-title":"A stepwise framework for the systematic development of lipid nanoparticles","volume":"12","author":"Basso","year":"2022","journal-title":"Biomol"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111230_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/med.20027","article-title":"Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies","volume":"25","author":"Blaheta","year":"2005","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.111230_bib7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2147\/NDT.S65874","article-title":"Psychiatric symptoms in glioma patients: from& nbsp;diagnosis to management","author":"Boele","year":"2015","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111230_bib8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00415-009-5156-9","article-title":"Efficacy of anti-epileptic drugs in patients with gliomas and seizures","volume":"256","author":"Breemen","year":"2009","journal-title":"J. Neurol."},{"issue":"3\u20134","key":"10.1016\/j.neuropharm.2026.111230_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0891-5849(00)00317-8","article-title":"Mitochondrial free radical generation, oxidative stress, and aging","volume":"29","author":"Cadenas","year":"2000","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111230_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020287","article-title":"Chitosan nanoparticles loaded with quercetin and valproic acid: a novel approach for enhancing antioxidant activity against oxidative stress in the SH-SY5Y human neuroblastoma cell line","volume":"12","author":"Canbolat","year":"2024","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111230_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.brainresrev.2010.05.003","article-title":"Looking at the blood \u2013 brain barrier : molecular anatomy and possible investigation approaches","volume":"64","author":"Cardoso","year":"2010","journal-title":"Brain Res. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111230_bib12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1471-4159.2005.03457.x","article-title":"Novel targets for valproic acid: Up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells","volume":"95","author":"Castro","year":"2005","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.cdd.4402233","article-title":"Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells","volume":"15","author":"Chen","year":"2008","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111230_bib14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in cancer","volume":"14","author":"Cho","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111230_bib15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3892\/ijmm.2016.2460","article-title":"Baicalein protects C6 glial cells against hydrogen peroxide-induced oxidative stress and apoptosis through regulation of the Nrf2 signaling pathway","volume":"37","author":"Choi","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111230_bib16","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s11011-018-0233-3","article-title":"Oxidative stress stimulates invasive potential in rat C6 and human U-87 MG glioblastoma cells via activation and cross-talk between PKM2, ENPP2 and APE1 enzymes","volume":"33","author":"Cholia","year":"2018","journal-title":"Metab. Brain Dis."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2026.111230_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-8981(02)00334-0","article-title":"Lipid peroxidation in cerebral tumors","volume":"327","author":"Cirak","year":"2003","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111230_bib18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.apsb.2021.08.013","article-title":"Gather wisdom to overcome barriers: well-designed nano-drug delivery systems for treating gliomas","volume":"12","author":"Cui","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111230_bib19","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1211\/0022357001774958","article-title":"Influence of nanoparticles on the brain-to-serum distribution and the metabolism of valproic acid in mice","volume":"52","author":"Darius","year":"2000","journal-title":"J. Pharm. Pharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111230_bib20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.111230_bib21","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Diederich","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1476-4598-7-82","article-title":"The prince and the pauper. A tale of anticancer targeted agents","volume":"7","author":"Due\u00f1as-Gonz\u00e1lez","year":"2008","journal-title":"Mol. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2026.111230_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/biof.5520080102","article-title":"Oxidative stress: role of mitochondria and protection by glutathione","volume":"8","author":"Fern\u00e1ndez-Checa","year":"1998","journal-title":"Biofactors"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111230_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/neuonc\/nop005","article-title":"Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines","volume":"12","author":"Fu","year":"2010","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1152\/jn.00581.2018","article-title":"Fluoxetine reverses brain radiation and temozolomide-induced anxiety and spatial learning and memory defect in mice","volume":"121","author":"Gan","year":"2019","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1152\/jn.00581.2018","article-title":"Fluoxetine reverses brain radiation and temozolomide-induced anxiety and spatial learning and memory defect in mice","volume":"121","author":"Gan","year":"2019","journal-title":"J. Neurophysiol."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111230_bib27","article-title":"Rising incidence of glioblastoma multiforme in a well-defined population","volume":"12","author":"Grech","year":"2020","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111230_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102412","article-title":"Epidemiology of glioblastoma multiforme\u2013literature review","volume":"14","author":"Grochans","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111230_bib29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3171\/2012.10.JNS12169","article-title":"Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme: clinical article","volume":"118","author":"Guthrie","year":"2013","journal-title":"J. Neurosurg."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111230_bib30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.clineuro.2007.04.007","article-title":"Relationship between DNA damage and total antioxidant capacity in patients with transitional meningioma","volume":"109","author":"Hanimoglu","year":"2007","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"April","key":"10.1016\/j.neuropharm.2026.111230_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejmech.2013.03.067","article-title":"A potential antitumor agent, ( 6-amino-1-methyl-5-nitrosouracilato-N3) - triphenylphosphine-gold (I): structural studies and in vivo biological effects against experimental glioma european journal of medicinal chemistry A potential antitumor agent","volume":"64","author":"Ill\u00e1n-cabeza","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111230_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2021.01.012","article-title":"Frontiers in the treatment of glioblastoma : past , present and emerging","volume":"171","author":"Iqbal","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"17","key":"10.1016\/j.neuropharm.2026.111230_bib33","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.188292.112","article-title":"Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells","volume":"26","author":"Janiszewska","year":"2012","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111230_bib34","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/pharmaceutics12090860","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as smart drug delivery systems in the treatment of glioblastoma multiforme","volume":"12","author":"Jnaidi","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111230_bib35","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1124\/dmd.112.044925","article-title":"Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance","volume":"40","author":"Kadam","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/01411590310001637066","article-title":"Antioxidant enzymes and lipid peroxidation in different stages of breast cancer","volume":"38","author":"Khanzode","year":"2004","journal-title":"Free Radic. Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111230_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in sprague\u2013dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"January","key":"10.1016\/j.neuropharm.2026.111230_bib38","first-page":"1","article-title":"Motor dysfunction as a primary symptom predicts poor outcome: multicenter study of glioma symptoms","volume":"13","author":"Kivioja","year":"2023","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111230_bib39","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3171\/jns.1980.53.6.0808","article-title":"An improved rat brain-tumor model","volume":"53","author":"Kobayashi","year":"1980","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06888-4","article-title":"Overcoming blood brain barrier with a dual purpose temozolomide loaded lactoferrin nanoparticles for combating glioma (SERP-17-12433)","volume":"7","author":"Kumari","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111230_bib41","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2621.1965.tb01845.x","article-title":"Reactivity of malonaldehyde with food constituents","volume":"30","author":"Kwon","year":"1965","journal-title":"J. Food Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111230_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1215\/15228517-2007-016","article-title":"Incidence of gliomas by anatomic location","volume":"9","author":"Larjavaara","year":"2007","journal-title":"Neuro Oncol."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111230_bib43","first-page":"883","article-title":"Increased expression of antioxidant enzymes in radioresistant variant from U251 human glioblastoma cell line","volume":"13","author":"Lee","year":"2004","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111230_bib44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bbi.2020.02.009","article-title":"AVNP2 protects against cognitive impairments induced by C6 glioma by suppressing tumour associated inflammation in rats","volume":"87","author":"Li","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111230_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.34172\/apb.2023.062","article-title":"Drug delivery of solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) to target brain tumors","volume":"13","author":"Mehrdadi","year":"2023","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.neuropharm.2026.111230_bib48","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.addr.2005.09.006","article-title":"Micro- and nanoparticulates","volume":"57","author":"Moshfeghi","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"March","key":"10.1016\/j.neuropharm.2026.111230_bib49","article-title":"Combination therapy with interferon-gamma as a potential therapeutic medicine in rat's glioblastoma: a multi-mechanism evaluation","volume":"305","author":"Moslemizadeh","year":"2022","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111230_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1601-1848.2004.00076.x","article-title":"Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice","volume":"3","author":"Moy","year":"2004","journal-title":"Gene Brain Behav."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111230_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27072202","article-title":"Optimization of the conditions of solid lipid nanoparticles (SLN) synthesis","volume":"27","author":"Musielak","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111230_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox14091121","article-title":"Oxidative stress and antioxidants in glioblastoma: mechanisms of action, therapeutic effects and future directions","volume":"14","author":"Nowacka","year":"2025","journal-title":"Antioxidants"},{"issue":"January","key":"10.1016\/j.neuropharm.2026.111230_bib53","first-page":"1","article-title":"Drug resistance in glioblastoma: the two faces of oxidative stress","volume":"7","author":"Olivier","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11011-026-01816-w","article-title":"From tumor reduction to behavioral improvement and cytokine balance: therapeutic role of petroleum ether extract of teucrium polium in a rat model of C6-induced glioblastoma","volume":"41","author":"Olyayie","year":"2026","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2026.111230_bib55","doi-asserted-by":"crossref","first-page":"IV1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111230_bib56","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2176\/nmc.52.186","article-title":"Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain","volume":"52","author":"Osuka","year":"2012","journal-title":"Neurol. Med.-Chir."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111230_bib57","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s13205-020-02427-7","article-title":"Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential","volume":"10","author":"Pathak","year":"2020","journal-title":"3 Biotech"},{"key":"10.1016\/j.neuropharm.2026.111230_bib58","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nlm.2018.06.014","article-title":"Inhibiting constitutive neurogenesis compromises long-term social recognition memory","volume":"155","author":"Pereira-Caixeta","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111230_bib59","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/13813450312331342328","article-title":"Lipid peroxidation, superoxide dismutase and catalase activities in brain tumor tissues","volume":"111","author":"Popov","year":"2003","journal-title":"Arch. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111230_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00182134","article-title":"Study of the antioxidant enzymes in human brain tumors","volume":"29","author":"Pu","year":"1996","journal-title":"J. Neuro Oncol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111230_bib61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/1570159X16666180302120925","article-title":"The delicate equilibrium between oxidants and antioxidants in brain glioma","volume":"17","author":"Ram\u00edrez-Exp\u00f3sito","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2026.111230_bib62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0009-8981(00)00219-9","article-title":"Role of antioxidant enzymes in brain tumours","volume":"296","author":"Rao","year":"2000","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111230_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27087","article-title":"Heliyon gene therapy in glioblastoma multiforme : can it be a role changer","volume":"10","author":"Rayati","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2026.111230_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/987495","article-title":"Valproic acid downregulates the expression of MGMT and sensitizes temozolomide-resistant glioma cells","volume":"2012","author":"Ryu","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111230_bib65","article-title":"Ghrelin is effective on passive avoidance memory by altering the expression of NMDAR and HTR1a genes in the hippocampus of Male wistar rats","volume":"10","author":"Sahraiian","year":"2021"},{"key":"10.1016\/j.neuropharm.2026.111230_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116625","article-title":"Synthesis, characterization, toxicity and morphology assessments of newly prepared microemulsion systems for delivery of valproic acid","volume":"338","author":"Sargazi","year":"2021","journal-title":"J. Mol. Liq."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/cancers11010005","article-title":"Glioblastoma: microenvironment and niche concept","volume":"11","author":"Schiffer","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"March 2021","key":"10.1016\/j.neuropharm.2026.111230_bib68","article-title":"The effect of early handling on anxiety-like behaviors of rats exposed to valproic acid pre-and post-natally","volume":"89","author":"Shafaghi","year":"2022","journal-title":"Neurotoxicol. Teratol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111230_bib70","doi-asserted-by":"crossref","first-page":"22493","DOI":"10.1002\/jcp.28813","article-title":"Neuropathological and genomic characterization of glioblastoma-induced rat model: how similar is it to humans for targeted therapy?","volume":"234","author":"Sharifzad","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib71","article-title":"Establishment of C6 brain glioma models through stereotactic technique for laser interstitial thermotherapy research","volume":"6","author":"Shi","year":"2015","journal-title":"Surg. Neurol. Int."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111230_bib72","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111230_bib73","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4103\/0976-3147.203829","article-title":"Impairments in quality of life and cognitive functions in long-term survivors of glioblastoma","volume":"8","author":"Solanki","year":"2017","journal-title":"J. Neurosci. Rural Pract."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13105-015-0453-5","article-title":"Effect of estrogen and\/or progesterone administration on traumatic brain injury-caused brain edema: the changes of aquaporin-4 and interleukin-6","volume":"72","author":"Soltani","year":"2016","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.neuropharm.2026.111230_bib75","first-page":"53","article-title":"Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model","author":"Son","year":"2006","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111230_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21129\/nerve.2016.2.2.17","article-title":"Establishment of a malignant glioma model in rats","volume":"2","author":"Song","year":"2016","journal-title":"The Nerve"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib77","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/br.2023.1695","article-title":"Prolonged use of temozolomide leads to increased anxiety and decreased content of aggrecan and chondroitin sulfate in brain tissues of aged rats","volume":"20","author":"Strokotova","year":"2023","journal-title":"Biomed. Reports"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111230_bib78","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.neuropharm.2026.111230_bib79","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.3390\/cancers13225868","article-title":"Novel treatment strategies for glioblastoma\u2014A summary","volume":"13","author":"Stylli","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10.1016\/j.neuropharm.2026.111230_bib80","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.3390\/nano12173054","article-title":"Preparation of solid lipid nanoparticle-ferrous sulfate by double emulsion method based on fat rich in monolaurin and stearic acid","volume":"12","author":"Subroto","year":"2022","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib81","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/carcin\/bgn242","article-title":"Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death","volume":"30","author":"Sun","year":"2009","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111230_bib82","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/1078-0432.CCR-03-0100","article-title":"Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells","volume":"10","author":"Takai","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"33","key":"10.1016\/j.neuropharm.2026.111230_bib83","doi-asserted-by":"crossref","first-page":"35004","DOI":"10.18632\/oncotarget.5253","article-title":"Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells","volume":"6","author":"Thotala","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib84","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/acs.jproteome.5c00734","article-title":"Mitochondrial metabolic reprogramming along with NRF2\/KEAP1-Mediated antioxidant mechanisms drive temozolomide resistance in glioblastoma multiforme","volume":"25","author":"Tomar","year":"2026","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.neuropharm.2026.111230_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.722754","article-title":"Valproic acid enhanced temozolomide-induced anticancer activity in human glioma through the p53\u2013PUMA apoptosis pathway","volume":"11","author":"Tsai","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib86","first-page":"15","article-title":"Valproic acid reduces spatial WORKING memory and cell proliferation in the HIPPOCAMPUS","volume":"166","author":"Umka","year":"2010","journal-title":"NSC"},{"key":"10.1016\/j.neuropharm.2026.111230_bib87","article-title":"Neurobehavioral effects in rats with experimentally induced glioblastoma after treatment with the mTOR-inhibitor rapamycin","volume":"184","author":"Unteroberd\u00f6rster","year":"2020","journal-title":"Neuropharmacology"},{"issue":"February","key":"10.1016\/j.neuropharm.2026.111230_bib88","article-title":"Early postnatal handling alters social behavior, learning, and memory of pre- and postnatal VPA-induced rat models of autism in a context-based manner","volume":"249","author":"Vakili Shahrbabaki","year":"2022","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111230_bib89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11060-011-0725-z","article-title":"Valproic acid sensitizes human glioma cells for temozolomide and \u03b3-radiation","volume":"107","author":"Van Nifterik","year":"2012","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.neuropharm.2026.111230_bib91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2009.01.011","article-title":"Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model","volume":"1261","author":"Wang","year":"2009","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111230_bib90","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0306-4522(02)00655-3","article-title":"Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells","volume":"116","author":"Wang","year":"2003","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111230_bib92","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11060-010-0447-7","article-title":"Impaired hippocampal synaptic plasticity in C6 glioma-bearing rats","volume":"103","author":"Wang","year":"2011","journal-title":"J. Neuro Oncol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111230_bib93","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00228-016-2167-1","article-title":"Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma","volume":"73","author":"Watanabe","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111230_bib94","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma","volume":"77","author":"Weller","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2026.111230_bib95","series-title":"Glioblastoma BT - Malignant Brain Tumors : State-Of-The-Art Treatment","first-page":"265","author":"Wirsching","year":"2017"},{"issue":"May","key":"10.1016\/j.neuropharm.2026.111230_bib96","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111230_bib97","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/00207450600553141","article-title":"Lipid peroxidation in patients with brain tumor","volume":"116","author":"Yi\u0307lmaz","year":"2006","journal-title":"Int. J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111230_bib98","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2014.12.044","article-title":"Autophagy inhibition improves the efficacy of curcumin\/temozolomide combination therapy in glioblastomas","volume":"358","author":"Zanotto-filho","year":"2015","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111230_bib99","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.clineuro.2008.11.008","article-title":"Alterations in lipid peroxidation and antioxidant status in different types of intracranial tumors within their relative peritumoral tissues","volume":"111","author":"Zengin","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111230_bib100","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826004053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826004053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:55:42Z","timestamp":1794027342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826004053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":97,"alternative-id":["S0028390826004053"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111230","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential and toxicological trade-offs of nanoparticle-enhanced valproic acid in glioblastoma: Behavioral and oxidative insights","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111230"}}